Journal Article
Research Support, U.S. Gov't, P.H.S.
Add like
Add dislike
Add to saved papers

Retinocytoma. A benign variant of retinoblastoma.

Six examples of a distinctive benign retinal tumor, occurring in five children and treated only by enucleation, were studied by light and electron microscopy and tested for S-100 protein, a glial-cell tissue marker. The small placoid, noninvasive lesions were composed entirely of benign-appearing cells with numerous fleurettes. These tumors showed no necrosis or mitotic activity. Ultrastructurally, they were composed predominantly of neuronal cells exhibiting photoreceptor differentiation. Some tumor cells had cytologic features of Müller's fibers and other glial cells that in one lesion stained positively for S-100 protein. In two patients there was a family history of retinoblastoma. All children were alive and well at follow-up examinations conducted three to 14 years after enucleation. To expand our concept of retinoblastoma to include this benign variant, we propose the term "retinocytoma." Although clinically and morphologically distinct from retinoblastoma, retinocytoma should carry the same genetic implication as its malignant counterpart.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app